4//SEC Filing
Encrantz Staffan 4
Accession 0000950170-25-039010
CIK 0001531177other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 7:22 PM ET
Size
12.7 KB
Accession
0000950170-25-039010
Insider Transaction Report
Form 4
Encrantz Staffan
Director10% Owner
Transactions
- Other
Common Stock
2025-03-10$2.53/sh+120,000$303,600→ 4,693,920 total(indirect: See footnote) - Other
Common Stock
2025-03-12$2.77/sh+243,000$673,110→ 5,086,920 total(indirect: See footnote) - Other
Common Stock
2025-03-11$2.71/sh+150,000$406,500→ 4,843,920 total(indirect: See footnote)
Holdings
- 632,456(indirect: See footnote)
Common Stock
- 1,029,516
Common Stock
Footnotes (6)
- [F1]These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President and sole director of Allegro Investment Inc., which is the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund for purposes of Rule 13d-3 under the Securities Exchange Act of 1934 (the "Exchange Act"). However, the Reporting Person does not have any pecuniary interest in the shares held by Allegro Investment Fund and disclaims beneficial ownership with respect to all such shares. Accordingly, this report is being provided voluntarily by the Reporting Person for informational purposes only and shall not be deemed an admission that the Reporting Person is the beneficial owner of any such shares for purposes of Section 16 under the Exchange Act or for any other purpose.
- [F2]The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $2.455 to $2.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $2.465 to $2.875 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $2.665 to $2.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F5]These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust for purposes of Rule 13d-3 under the Exchange Act. The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 under the Exchange Act or for any other purpose), except to the extent of his pecuniary interest therein, if any.
- [F6]Includes (i) 1,012,150 shares of Common Stock and (ii) 17,366 restricted stock units, which are subject to vesting as previously reported.
Documents
Issuer
Sight Sciences, Inc.
CIK 0001531177
Entity typeother
Related Parties
1- filerCIK 0001870875
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 7:22 PM ET
- Size
- 12.7 KB